1 / 7

Procedural Sedation Tintinalli Chap. 38

Procedural Sedation Tintinalli Chap. 38. Prepared by Darren Shiley , D.O. Levels of Sedation. Minimal Sedation drug-induced anxiolysis Patient responds normally to verbal commands Cognitive function and coordination may be impaired Ventilatory and cardiovascular function is unaffected

lana
Download Presentation

Procedural Sedation Tintinalli Chap. 38

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Procedural SedationTintinalli Chap. 38 Prepared by Darren Shiley, D.O.

  2. Levels of Sedation • Minimal Sedation • drug-induced anxiolysis • Patient responds normally to verbal commands • Cognitive function and coordination may be impaired • Ventilatory and cardiovascular function is unaffected • Moderate Sedation and Analgesia • PSA or “conscious sedation” • Drug-induce depression of consciousness • Patient responds purposefully to verbal commands alone or with light tactile stimulation • Deep Sedation and Analgesia • Patient cannot be easily aroused but responds purposefully after repeated or painful stimulation • May require assistance in maintaining patent airway and spontaneous ventilation may be inadequate • Anesthesia • Drug-induced loss of consciousness • Patient cannot be aroused even with painful stimulation • Requires assistance in maintaining a patent airway and may need positive pressure ventilation • Cardiovascular function may be impaired

  3. Procedural Sedation and Analgesia • Indications • Treatment of severe pain • Attenuation of pain and anxiety associated with procedures • Rapid tranquilization • Need to perform a diagnostic procedure • Agents • Often have narrow therapeutic index • Should be given in small incremental doses • Monitoring • Should be performed by another provider who understands the pharmacology, possesses sound airway-management skills, and will not be distracted by other tasks

  4. Patient Assessment • Classification • I • Normal healthy patient • II • Mild systemic disease • Asthma • Controlled diabetes • III • Moderate systemic disease • Stable angina • Diabetes with hyperglycemia • Moderate COPD • IV • Severe systemic disease • Unstable angina • DKA • V • Moribund • +E • All ED patients

  5. Agents in PSA • Opioids • Morphine • Fentanyl • Anxiolytics • Midazolam • Anesthetic Agents • Propofol • Etomidate • Ketamine • Methohexital

  6. Midazolam • Benzodiazepine • potentiate inhibitory activity of GABA in CNS • Result in sedation, amnesia, anxiolysis, respiratory depression, and anticonvulsant effects • Use cautiously in combination with alcohol or opioids d/t increased sedative and respiratory-depressant effects

  7. Antidotal Agents • Naloxone • Competitive opioid antagonist at µ receptors • Indicated for reversal of unwanted respiratory depression after opioid administration • May not reverse fentanyl-induced chest wall rigidity • Patients who are opioid dependent may develop withdrawal with large doses • Flumazenil • Competitive antagonist of benzodiazepines • Use with caution in benzodiazepine-dependent patients • Indicated for reversal of respiratory depression caused by benzodiazepines

More Related